CheckMyRecalls

Teva Octreotide for injectable suspension recall

Teva Octreotide for injectable suspension recalled due to potential drug quality issues

Published
13 Jan 2026
Agency
Health Canada
Country
Canada

The hazard

Product quality

What to do

If you have an affected product, do not use it. Speak to your health care professional immediately to obtain an alternative or replacement product. If you are unsure whether your product is affected, check with your pharmacy. Seek medical attention if you have used this product and are experiencing symptoms of infection, or other unexpected symptoms or side effects. Return affected product(s) to the pharmacy where it was purchased for proper disposal. Consult a health care professional if you have used the affected product and have health concerns. Contact Teva Canada Limited by calling toll-free at 1-800-268-4127, option 3, or by email at [email protected], if you have questions about this recall. Report any health product-related side effects or complaints to Health Canada.

  • Stop using the product until you have checked whether yours is affected.
  • Compare model numbers, batch codes and dates on the label with the official notice.
  • Contact the company in the notice for your refund, repair or replacement. Do not sell or give it away.
Read the official Health Canada notice

Source: Health Canada, published 13 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.